Company Profile

Relay Therapeutics develops precision medicines using computational modeling, machine learning, molecular simulations, and experimental biology. Its Dynamo platform studies how proteins move and function to identify potential drug-binding sites, discover promising compounds, and optimize drug candidates. The company’s pipeline focuses on oncology and genetic diseases, including programs targeting breast cancer, solid tumors, and vascular anomalies.